Jenburkt Pharmaceuticals Limited (JENBURPH.BO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ashish Uttam Bhuta | Chairman & MD | 22.27M | -- | 1973 |
| Mr. Dilip Harkisandas Bhuta | CFO & Whole Time Director | 6.57M | -- | 1952 |
| Mr. Ashish Rasiklal Shah | Compliance Officer & Company Secretary | -- | -- | -- |
| Mr. Bhanudas Narayan Kadam | Head of QA/QC | -- | -- | -- |
| Mr. Jayesh D. Tanna | Head of Information Technology | -- | -- | 1965 |
| Mr. Barani Dharan Sivaprakasam | Head of Sales (Wellness Division) | -- | -- | 1978 |
| Mr. Uday Kalele | Head of R&D and Projects at Plant, Sihor | -- | -- | 1956 |
| Mr. Vinay L. Bhatt | Head of International Business | -- | -- | 1968 |
| Mr. Seshachalam Janakiraman | Head of Sales & Marketing Pharmaceutical Vertical (India) | -- | -- | -- |
| Mr. Mahender Paul Singh | Head of Sales & Marketing (Brenz Division) | -- | -- | 1960 |
Jenburkt Pharmaceuticals Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 752
Description
Jenburkt Pharmaceuticals Limited researches and develops, manufactures, and markets pharmaceutical and healthcare products in India. It offers products in various therapeutic areas, such as pain management, analgesic and anti-pyretics, muscle relaxants, nutraceuticals, neuropathic pain, anti-arthritic, anti-infectives, antifungals, antiulcerants/antacids, aphrodisiacs, antimalarials, anthelmintics, cough and cold, and anti- diabetics, as well as consumer products. The company offers its products under the Allerzine, CartiSafe Forte, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, Zydol Suspension, and Zixa brand names. The company provides its products through stockists, doctors, pharmacies, chemists, large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. It exports its products to approximately 13 countries worldwide. Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.
Corporate Governance
Upcoming Events
May 26, 2025 at 10:59 AM UTC - May 30, 2025 at 12:00 PM UTC
Jenburkt Pharmaceuticals Limited Earnings Date
Recent Events
July 23, 2024 at 12:00 AM UTC
Ex-Dividend Date